View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

HHS/CMS RIN: 0938-AT56 Publication ID: Spring 2020 
Title: Clinical Laboratory Improvement Amendments (CLIA) Fees (CMS-3356) 
Abstract:

This proposed rule follows the notice with comment published on December 31, 2018. This rule would update fees for determination of program compliance and additional fees for laboratories established under the Clinical Laboratory Improvement Amendments (CLIA) regulations as well as the collection of other fees we are authorized to collect, such as fees for revised certificates, post survey follow-up visits, complaint investigations, and activities related to imposition of sanctions.

 
Agency: Department of Health and Human Services(HHS)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: No  Unfunded Mandates: No 
EO 13771 Designation: Other 
CFR Citation: 42 CFR 493   
Legal Authority: 42 U.S.C. 263a   
Legal Deadline:  None
Timetable:
Action Date FR Cite
Notice With Comment Period  12/31/2018  83 FR 67723   
Notice Comment Period End  03/01/2019 
NPRM  12/00/2020 
Regulatory Flexibility Analysis Required: Undetermined  Government Levels Affected: Undetermined 
Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Jessica Wright
Health Insurance Specialist
Department of Health and Human Services
Centers for Medicare & Medicaid Services
Center for Clinical Standards and Quality, MS: C2-21-16, 7500 Security Boulevard,
Baltimore, MD 21244
Phone:410 786-3838
Email: jessica.wright@cms.hhs.gov